Conference News

Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value

Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value

By

Stringent CR criteria may not predict clinical outcomes for patients with multiple myeloma.

A Retrospective Look at Drug Sensitivity Before and After Checkpoint Blockade in R/R NHL

A Retrospective Look at Drug Sensitivity Before and After Checkpoint Blockade in R/R NHL

By

Checkpoint-based therapies may sensitize patients to subsequent therapies.

Prior Bortezomib Lowers Incidence of Lenalidomide-Induced Skin Toxicity in Multiple Myeloma

Prior Bortezomib Lowers Incidence of Lenalidomide-Induced Skin Toxicity in Multiple Myeloma

By

A study presented at ESMO 2018 demonstrated that incidence of skin toxicity in patients with multiple myeloma undergoing lenalidomide therapy was lower in those who received prior bortezomib.

Nonadherence to Tamoxifen Higher Than Reported Among Premenopausal Patients With Breast Cancer

Nonadherence to Tamoxifen Higher Than Reported Among Premenopausal Patients With Breast Cancer

By

Assessment of a subgroup of a cohort study revealed that many patients undergoing tamoxifen therapy for early-stage breast cancer do not adhere to their prescribed treatment, even though they claim adherence on patient surveys.

Chemotherapy Side Effects in Women vs Men: Broader Range, More Severe

Chemotherapy Side Effects in Women vs Men: Broader Range, More Severe

By

An analysis of pooled data from 4 randomized controlled clinical trials revealed that male and female patients experience different chemotherapy side effects and at different severities, according to a poster presented at ESMO 2018 Congress.

Routine Scanning in Early-Stage Breast Cancer Unnecessary, Greater Harms

Routine Scanning in Early-Stage Breast Cancer Unnecessary, Greater Harms

By

A study presented at 2018 ASCO Quality Care Symposium demonstrates further support for Choosing Wisely Initiative's recommendations against routine scanning in early-stage breast cancer.

SCOOPs Program Improves Patient Experience, Reduces Costs

SCOOPs Program Improves Patient Experience, Reduces Costs

By

Researchers report on the effectiveness results of the Supportive Care of Oncology Patients (SCOOPs) Program were presented at the 2018 ASCO Quality Care Symposium.

Navigating Patients with Hematologic Malignancies

Navigating Patients with Hematologic Malignancies

By

Patients with hematologic cancers often require a combination of inpatient and outpatient care. The oncology nurse navigator is an ideal care provider to help patients manage their care and transitions between care settings, according to a presentation at the 2018 ONA Navigation Summit.

Lung Cancer: What Nurse Navigators Need to Know in 2018

Lung Cancer: What Nurse Navigators Need to Know in 2018

By

There have been many recent changes in lung cancer, including updated early detection possibilities and changes in diagnostic procedures, reporting, and treatment options. These are reviewed in a presentation at the 2018 ONA Navigation Summit.

Navigating the Benefits and Challenges of Immunotherapy

Navigating the Benefits and Challenges of Immunotherapy

By

A review of immunotherapy — what they are, how they work, and what to watch for — was presented at the 2018 ONA Navigation Summit.

Difficult Conversations: The Role of Nurse Navigator

Difficult Conversations: The Role of Nurse Navigator

By

Suggestions for communication points that improve the experience of patients with cancer through nurse navigation were presented at the 2018 ONA Navigation Summit.

Navigating Patients With Gastrointestinal Cancer

Navigating Patients With Gastrointestinal Cancer

By

The unique challenges that face both oncology nurse navigators specializing in gastrointestinal cancer and patients with these diseases are reviewed in a presentation at the 2018 ONA Navigation Summit.

Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator

Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator

By

The head and neck oncology nurse navigator (ONN) is a unique and critical position to help patients, their families, and their caregivers as they face their diagnosis and undergo treatment.

Developing a Specialty Multidisciplinary Breast Clinic

Developing a Specialty Multidisciplinary Breast Clinic

By

Creating a multidisciplinary breast clinic can ensure that patients with breast cancer receive care that is timely, effective, and efficient, according to a presentation at the 2018 ONA Navigation Summit.

Development of App Aimed at Improving Patient Navigation Services in Underserved Populations

Development of App Aimed at Improving Patient Navigation Services in Underserved Populations

By

The technology will facilitate data entry for patient navigation activities, evaluation of one or more patient navigators (PNs), and generate reports.

The Health Care Mortgage: Understanding the Complexities of Financial Toxicity

The Health Care Mortgage: Understanding the Complexities of Financial Toxicity

By

Cost of cancer care is more than co-pays for medications and treatment. Cancer can affect a patient's ability to work compounding the financial costs of their care, as described in this presentation at the 2018 ONA Navigation Summit.

Building a Navigation Program: A Review of the Key Components

Building a Navigation Program: A Review of the Key Components

By

A discussion and review of how to develop a successful nurse or patient navigation program is presented at the 2018 ONA Navigation Summit.

Advanced Concepts in Oncology Navigation

Advanced Concepts in Oncology Navigation

By

Now well established within the cancer care continuum, this presentation at the 2018 ONA Navigation Summit discussed the forces expanding the use of oncology navigation as well as the evolving role of the oncology nurse navigator.

The Importance of Self Care for Oncology Nurse Navigators: Resilience and Empowerment

The Importance of Self Care for Oncology Nurse Navigators: Resilience and Empowerment

By

Oncology nurse navigators tend to forget the most important person in the cancer care continuum: themselves. In this keynote presentation at the 2018 ONA Navigation Summit, Deborah Boyle, RN, MSN, AOCNS®, FAAN, talks about the importance of self care.

Association Between Multiple Myeloma With VTE and Increased Mortality at 2, 5 Years

Association Between Multiple Myeloma With VTE and Increased Mortality at 2, 5 Years

By

A study presented at the 2018 ASCO Annual Meeting investigated the mortality risk for patients with multiple myeloma who develop VTE.

Weekend Admission for Acute Leukemia Negatively Affects Mortality Rate

Weekend Admission for Acute Leukemia Negatively Affects Mortality Rate

By

An assessment of more than 71,000 patients with leukemia demonstrated the difference in outcomes for patients admitted to hospital on the weekend vs weekday. Findings were presented at the 2018 ASCO Annual Meeting.

Intervention With Lay Health Workers Has Positive Effect on Cancer Patients' Experience

Intervention With Lay Health Workers Has Positive Effect on Cancer Patients' Experience

By

An intervention utilizing lay health workers supervised by NPs lowered health care costs and improved patient satisfaction.

Head and Neck Cancer Survival Improved When irAEs Occur During Anti-PD-1 Therapy

Head and Neck Cancer Survival Improved When irAEs Occur During Anti-PD-1 Therapy

By

Researchers evaluated whether the development of irAEsc among patients with metastatic head and neck cancer who have failed platinum-based chemotherapy could improve patient outcomes.

Dexrazoxane May Reduce Cardiotoxicity in Pediatric AML

Dexrazoxane May Reduce Cardiotoxicity in Pediatric AML

By

Children's Oncology Group study reported on the effect of dexrazoxane on cardiotoxicity of anthracycline-containing regimens in pediatric patients with AML at the 2018 ASCO Annual Meeting.

Walking Program Improved Physical Function, But Not Fatigue, After RT for Breast Cancer

Walking Program Improved Physical Function, But Not Fatigue, After RT for Breast Cancer

By

In a multicenter phase 2 study, the Walk With Ease program was evaluated for its effectiveness in reducing radiotherapy-associated fatigue vs usual care in older patients with breast cancer. Results were presented at 2018 ASCO Annual Meeting.

Overall Survival Benefit With Prostate Cancer Vaccine Not Duplicated in Phase 3 Trial

Overall Survival Benefit With Prostate Cancer Vaccine Not Duplicated in Phase 3 Trial

By

Latest findings do not confirm an overall survival (OS) benefit found in a previous randomized phase 2 trial.

Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer

Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer

By

Study presented at 2018 ASCO Annual Meeting determined the feasibility of using a mindfulness intervention to improve quality of life and confidence in advance care planning discussions among patient-family caregiver dyads.

Palliative Issues Inadequately Addressed Among Hospitalized Cancer Patients

Palliative Issues Inadequately Addressed Among Hospitalized Cancer Patients

By

Consultations for palliative care for hospitalized highly symptomatic patients with cancer is low regardless of curability or whether patient has hematologic or solid cancer, a study presented at 2018 ASCO has shown.

Dose-Dense Chemotherapy for Breast Cancer May Impair Lung Function

Dose-Dense Chemotherapy for Breast Cancer May Impair Lung Function

By

Long-term analysis determined the effect of postadjuvant dose-dense chemotherapy on DLCO among women with breast cancer.

Patient-Provider Conversations Regarding Financial Impact of Cancer Therapy Lacking

Patient-Provider Conversations Regarding Financial Impact of Cancer Therapy Lacking

By

Survey results presented at the 2018 ASCO Annual Meeting demonstrated the effects of financial toxicity on patients with early stage breast cancer.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs